Literature DB >> 24833265

Immobility responses between mouse strains correlate with distinct hippocampal serotonin transporter protein expression and function.

Man Tang1, Tao He1, Qing-yan Meng2, John Isaac Broussard3, Lan Yao4, Yao Diao5, Xiu-bo Sang6, Qing-peng Liu6, Ying-jun Liao7, Yuge Li8, Shulei Zhao9.   

Abstract

Mouse strain differences in immobility and in sensitivity to antidepressants have been observed in the forced swimming test (FST) and the tail suspension test (TST). However, the neurotransmitter systems and neural substrates that contribute to these differences remain unknown. To investigate the role of the hippocampal serotonin transporter (5-HTT), we measured baseline immobility and the immobility responses to fluoxetine (FLX) in the FST and the TST in male CD-1, C57BL/6, DBA and BALB/c mice. We observed strain differences in baseline immobility time, with CD-1 mice showing the longest and DBA mice showing the shortest. In contrast, DBA and BALB/c mice showed the highest sensitivity to FLX, whereas CD-1 and C57BL/6 mice showed the lowest sensitivity. Also we found strain differences in both the total 5-HTT protein level and the membrane-bound 5-HTT level (estimated by V max) as follows: DBA>BALB/c>CD-1=C57BL/6. The uptake efficiency of the membrane-bound 5-HTT (estimated by 1/K m) was highest in DBA and BALB/c mice and lowest in CD-1 and C57BL/6 mice. A correlation analysis of subregions within the hippocampus revealed that immobility time was negatively correlated with V max and positively correlated with K m in the hippocampus. Therefore a higher uptake capacity of the membrane-bound 5-HTT in the hippocampus was associated with lower baseline immobility and greater sensitivity to FLX. These results suggest that alterations in hippocampal 5-HTT activity may contribute to mouse strain differences in the FST and the TST.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24833265     DOI: 10.1017/S146114571400073X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  5 in total

1.  Mice exposed to bisphenol A exhibit depressive-like behavior with neurotransmitter and neuroactive steroid dysfunction.

Authors:  Frances Xin; Erin Fischer; Christopher Krapp; Elizabeth N Krizman; Yemin Lan; Clementina Mesaros; Nathaniel W Snyder; Amita Bansal; Michael B Robinson; Rebecca A Simmons; Marisa S Bartolomei
Journal:  Horm Behav       Date:  2018-05-18       Impact factor: 3.587

2.  Deletion of fibroblast growth factor 22 (FGF22) causes a depression-like phenotype in adult mice.

Authors:  Aislinn J Williams; Patricia Yee; Mitchell C Smith; Geoffrey G Murphy; Hisashi Umemori
Journal:  Behav Brain Res       Date:  2016-03-29       Impact factor: 3.332

3.  Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.

Authors:  Zeng-Liang Jin; Xiao-Fei Chen; Yu-Hua Ran; Xiao-Rong Li; Jie Xiong; Yuan-Yuan Zheng; Na-Na Gao; Yun-Feng Li
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

4.  Gene expression profile associated with Asmt knockout-induced depression-like behaviors and exercise effects in mouse hypothalamus.

Authors:  Wenbin Liu; Weina Liu; Zhuochun Huang; Jie Xia; Zhiming Cui; Lingxia Li; Zhengtang Qi
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

5.  STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior.

Authors:  Eryan Kong; Sonja Sucic; Francisco J Monje; Giorgia Savalli; Weifei Diao; Deeba Khan; Marianne Ronovsky; Maureen Cabatic; Florian Koban; Michael Freissmuth; Daniela D Pollak
Journal:  Sci Rep       Date:  2015-03-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.